These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 6753908

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB, Morton JJ, Brown JJ, Davies DL, Fraser R, Kelly P, Leckie B, Lever AF, Robertson JI.
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Captopril withdrawal after chronic therapy.
    Vlasses PH, Koffer H, Ferguson RK, Green PJ, McElwain GE.
    Clin Exp Hypertens (1978); 1981 Sep; 3(5):929-37. PubMed ID: 7026198
    [Abstract] [Full Text] [Related]

  • 5. Long-term efficacy of angiotensin-converting-enzyme inhibition with captopril in mild-to-moderate essential hypertension.
    Stumpe KO, Overlack A, Kolloch R, Schreyer S.
    Br J Clin Pharmacol; 1982 Sep; 14 Suppl 2(Suppl 2):121S-126S. PubMed ID: 6291563
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)].
    Overlack A, Stumpe KO, Heck I, Krück F.
    Dtsch Med Wochenschr; 1980 Apr 11; 105(15):505-9. PubMed ID: 6244920
    [Abstract] [Full Text] [Related]

  • 8. Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity.
    Waeber B, Gavras I, Brunner HR, Cook CA, Charocopos F, Gavras HP.
    Am Heart J; 1982 Mar 11; 103(3):384-90. PubMed ID: 6278905
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA, Baker KM, Ayers CR, Weaver BA, Lehman MR.
    J Cardiovasc Pharmacol; 1985 Mar 11; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [Abstract] [Full Text] [Related]

  • 11. Effects of single dose administration of angiotension covering enzyme inhibitor (captopril) on blood pressure, plasma renin activity and plasma aldosterone in patients with essential hypertension. A proposal for the captopril test.
    Kodama K, Morotomi Y, Kida O, Higa T, Someya N, Kondo K, Tanaka K.
    Nihon Jinzo Gakkai Shi; 1984 Sep 11; 26(9):1243-9. PubMed ID: 6392644
    [No Abstract] [Full Text] [Related]

  • 12. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP, Karlberg BE, Nilsson OR, Wettre S.
    Acta Med Scand Suppl; 1981 Sep 11; 646():98-105. PubMed ID: 7018190
    [Abstract] [Full Text] [Related]

  • 13. Hormonal changes with long-term converting-enzyme inhibition by captopril in essential hypertension.
    Matthews PG, McGrath BP, Johnston CI.
    Clin Sci (Lond); 1979 Dec 11; 57 Suppl 5():135s-138s. PubMed ID: 232017
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor.
    Sullivan JM, Ginsburg BA, Ratts TE, Johnson JG, Barton BR, Kraus DH, McKinstry DN, Muirhead EE.
    Hypertension; 1979 Dec 11; 1(4):397-401. PubMed ID: 232084
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of drug-resistant hypertension with minoxidil or angiotensin-converting enzyme inhibitor: blood pressure, renin, aldosterone, and electrolyte responses.
    Baer L, Radichevich I, Williams GS.
    J Cardiovasc Pharmacol; 1980 Dec 11; 2 Suppl 2():S206-16. PubMed ID: 6156357
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients.
    Ogihara T, Maruyama A, Hata T, Mikami H, Nakamaru M, Naka T, Ohde H, Kumahara Y.
    Clin Pharmacol Ther; 1981 Sep 11; 30(3):328-35. PubMed ID: 6268347
    [Abstract] [Full Text] [Related]

  • 19. Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol.
    MacGregor GA, Markandu ND, Banks RA, Bayliss J, Roulston JE, Jones JC.
    Br Med J (Clin Res Ed); 1982 Mar 06; 284(6317):693-6. PubMed ID: 6802291
    [Abstract] [Full Text] [Related]

  • 20. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA, Drayer JI, Priest RT, Chen TC.
    Am J Nephrol; 1982 Mar 06; 2(1):6-11. PubMed ID: 6295161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.